Körper S - Search Results

1

Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.

Jahrsdörfer B, Groß R, Seidel A, Wettstein L, Ludwig C, Schwarz T, Körper S, Rojewski M, Lotfi R, Weinstock C, Seifried E, Corman VM, Drosten C, Münch J, Schrezenmeier H. Jahrsdörfer B, et al. Among authors: korper s. J Immunol. 2021 Jun 1;206(11):2614-2622. doi: 10.4049/jimmunol.2100036. Epub 2021 May 12. J Immunol. 2021. PMID: 33980583

2

The K+ channel openers diazoxide and NS1619 induce depolarization of mitochondria and have differential effects on cell Ca2+ in CD34+ cell line KG-1a.

Körper S, Nolte F, Rojewski MT, Thiel E, Schrezenmeier H. Körper S, et al. Exp Hematol. 2003 Sep;31(9):815-23. doi: 10.1016/s0301-472x(03)00199-1. Exp Hematol. 2003. PMID: 12962728 Free article.

3

The role of mitochondrial targeting in arsenic trioxide-induced apoptosis in myeloid cell lines.

Körper S, Nolte F, Thiel E, Schrezenmeier H, Rojewski MT. Körper S, et al. Br J Haematol. 2004 Jan;124(2):186-9. doi: 10.1046/j.1365-2141.2003.04742.x. Br J Haematol. 2004. PMID: 14687028 Free article.

4

Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.

Rojewski MT, Körper S, Thiel E, Schrezenmeier H. Rojewski MT, et al. Among authors: korper s. Oncol Rep. 2004 Feb;11(2):509-13. Oncol Rep. 2004. PMID: 14719092

5

Depolarization of mitochondria and activation of caspases are common features of arsenic(III)-induced apoptosis in myelogenic and lymphatic cell lines.

Rojewski MT, Körper S, Thiel E, Schrezenmeier H. Rojewski MT, et al. Among authors: korper s. Chem Res Toxicol. 2004 Jan;17(1):119-28. doi: 10.1021/tx034104+. Chem Res Toxicol. 2004. PMID: 14727926

6

Depolarisation of the plasma membrane in the arsenic trioxide (As2O3)-and anti-CD95-induced apoptosis in myeloid cells.

Nolte F, Friedrich O, Rojewski M, Fink RH, Schrezenmeier H, Körper S. Nolte F, et al. Among authors: korper s. FEBS Lett. 2004 Dec 3;578(1-2):85-9. doi: 10.1016/j.febslet.2004.10.075. FEBS Lett. 2004. PMID: 15581621 Free article.

7

Arsenic trioxide therapy in acute promyelocytic leukemia and beyond: from bench to bedside.

Rojewski MT, Körper S, Schrezenmeier H. Rojewski MT, et al. Among authors: korper s. Leuk Lymphoma. 2004 Dec;45(12):2387-401. doi: 10.1080/10428190412331272686. Leuk Lymphoma. 2004. PMID: 15621751 Review.

8

S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes.

Eisenbacher JL, Schrezenmeier H, Jahrsdörfer B, Kaltenmeier C, Rojewski MT, Yildiz T, Beyer T, Erle A, Wiegmann DS, Grassl S, Hang R, Körper S, Wiesneth M, Lotze MT, Lotfi R. Eisenbacher JL, et al. Among authors: korper s. J Immunol. 2014 Jun 15;192(12):6102-10. doi: 10.4049/jimmunol.1303144. Epub 2014 May 2. J Immunol. 2014. PMID: 24795458 Clinical Trial.

9

[Aplastic anemia].

Schrezenmeier H, Körper S, Höchsmann B. Schrezenmeier H, et al. Among authors: korper s. Dtsch Med Wochenschr. 2014 Dec;139(49):2503-6. doi: 10.1055/s-0034-1387407. Epub 2014 Nov 25. Dtsch Med Wochenschr. 2014. PMID: 25423456 Review. German. No abstract available.

10

Immunosuppressive therapy for transplant-ineligible aplastic anemia patients.

Schrezenmeier H, Körper S, Höchsmann B. Schrezenmeier H, et al. Among authors: korper s. Expert Rev Hematol. 2015 Feb;8(1):89-99. doi: 10.1586/17474086.2015.978759. Expert Rev Hematol. 2015. PMID: 25572607 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page